<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03692364</url>
  </required_header>
  <id_info>
    <org_study_id>Protesteam_ceram</org_study_id>
    <nct_id>NCT03692364</nct_id>
  </id_info>
  <brief_title>Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Total Hip Arthroplasty</brief_title>
  <official_title>Randomized Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Uncemented Total Hip Arthroplasty: A Radiostereometry Study Including 104 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Nordic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polyethylene wear debris from metal-on-polyethylene articulations are one of the main causes
      of periprosthetic bone loss and non-infectious loosening in total hip arthroplasty. Ceramic
      articulations have a very low wear rate when measured in the laboratory and the
      investigator's hypothesis is that hip arthroplasty with an all ceramic articulation will have
      less osteolysis and wear in addition to equally good fixation and clinical outcome compared
      to the same hip arthroplasty design with a metal-on-polyethylene joint.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2, 2003</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Osteolysis frequency change between 7 and 15 years</measure>
    <time_frame>Change between 7 to 15 years after surgery</time_frame>
    <description>Osteolysis frequency (%) measured with computed tomography,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Osteolysis size change between 7 and 15 years</measure>
    <time_frame>Change between 7 and 15 years after surgery</time_frame>
    <description>Osteolysis size (cm3) measured with computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Articulation wear at 7 years</measure>
    <time_frame>At 7 years after surgery</time_frame>
    <description>Articulation wear as measured with radiostereometry, mm/year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Articulation wear at 15 years</measure>
    <time_frame>15 years after surgery</time_frame>
    <description>Articulation wear as measured with radiostereometry, mm/year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant fixation at 7 years</measure>
    <time_frame>7 years after surgery</time_frame>
    <description>Stem and cup translation (mm/year) and rotation (degrees/year) measured with radiostereometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant fixation at 15 years</measure>
    <time_frame>At 15 years after surgery</time_frame>
    <description>Stem and cup translation (mm/year) and rotation (degrees/year) measured with radiostereometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical function at 7 years</measure>
    <time_frame>7 years after surgery</time_frame>
    <description>Harris Hip Score (0-100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical function at 15 years</measure>
    <time_frame>15 years after surgery</time_frame>
    <description>Harris Hip Score (0-100)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Arthroplasty Complications</condition>
  <arm_group>
    <arm_group_label>Metal-on-conventional polyethylene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Uncemented hip arthroplasty (ABG-2, Stryker, Mahwah NJ, US) with a CoCr prosthetic femoral head and an acetabular liner made of intermedially cross-linked polyethylene polyethylene (Duration, Stryker, Mahwah, NJ, US).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ceramic-on-ceramic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uncemented hip arthroplasty (ABG-2, Stryker, Mahwah NJ, US) with a prosthetic femoral head and an acetabular liner made of alumina ceramic (Biolox Forte, Ceramtec, Plochingen, Germany).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ceramic-on-ceramic uncemented hip arthroplasty</intervention_name>
    <arm_group_label>Ceramic-on-ceramic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metal-on-polyethylene uncemented total hip arthroplasty</intervention_name>
    <arm_group_label>Metal-on-conventional polyethylene</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary osteoarthritis

          -  secondary osteoarthritis caused by idiopathic osteonecrosis, dysplasia or childhood
             disease (Mb Perthes, epiphysiolysis)

        Exclusion Criteria:

          -  inflammatory arthritis

          -  hip joint infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 20, 2018</study_first_submitted>
  <study_first_submitted_qc>September 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2018</study_first_posted>
  <last_update_submitted>September 30, 2018</last_update_submitted>
  <last_update_submitted_qc>September 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Per-Erik Johanson</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>biomaterials</keyword>
  <keyword>Implant wear</keyword>
  <keyword>hip arthroplasty</keyword>
  <keyword>osteolysis</keyword>
  <keyword>aseptic loosening</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

